Brainsway stock sale pulls in about $67.6M

10/7/2013 | Globes (Israel)

Brainsway, maker of the Deep Transcranial Magnetic Stimulation, or TMS, device designed to treat depression, has secured about $6.76 million in a shares offering in Israel. Over the weekend, the company also obtained $1 million in initial payments from a Japanese distributor that agreed to market its depression systems.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care